These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 12542475)

  • 1. Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes.
    Bowen D; Culligan D; Jowitt S; Kelsey S; Mufti G; Oscier D; Parker J;
    Br J Haematol; 2003 Jan; 120(2):187-200. PubMed ID: 12542475
    [No Abstract]   [Full Text] [Related]  

  • 2. [Myeloproliferative syndromes].
    Ganser A
    Ther Umsch; 1996 Feb; 53(2):97-102. PubMed ID: 8629270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic spectrum in the treatment of myelodysplastic syndromes.
    Hofmann WK; Baldus C; Uharek L; Thiel E
    Expert Opin Pharmacother; 2004 Dec; 5(12):2451-8. PubMed ID: 15571463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of MDS].
    Usuki K
    Rinsho Ketsueki; 2014 Oct; 55(10):1882-92. PubMed ID: 25297752
    [No Abstract]   [Full Text] [Related]  

  • 5. Granulocyte colony-stimulating factor and erythropoietin for the anemia of myelodysplastic syndromes: a real improvement with respect to erythropoietin alone?
    Musto P; Falcone A; Carotenuto M; Catalano L; Cennamo A; Rotoli B
    Blood; 1994 Sep; 84(5):1687-8. PubMed ID: 7520783
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk-based management of myelodysplastic syndrome.
    Steensma DP; Tefferi A
    Oncology (Williston Park); 2007 Jan; 21(1):43-54; discussion 57-8, 62. PubMed ID: 17313156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic growth factors for the treatment of myelodysplastic syndromes.
    Hast R; Bernell P
    Acta Haematol Pol; 1991; 22(2):203-7. PubMed ID: 1726768
    [No Abstract]   [Full Text] [Related]  

  • 8. [Myelodysplastic syndromes: treatment strategy up-to-date].
    Tohyama K
    Rinsho Ketsueki; 2014 Jan; 55(1):12-21. PubMed ID: 24492032
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of bone marrow transplantation in the treatment of myelodysplastic syndromes.
    Schultz AB; Geller RB; Hillyer CD
    J Hematother; 1995 Aug; 4(4):323-34. PubMed ID: 7489147
    [No Abstract]   [Full Text] [Related]  

  • 10. [The myelodysplastic syndrome II. New therapeutic principles, course and prognosis].
    Hasselbalch HC; Juhl BR; Hansen PB
    Ugeskr Laeger; 2002 Jan; 164(4):479-82. PubMed ID: 11838418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelodysplastic syndrome.
    Hofmann WK; Koeffler HP
    Annu Rev Med; 2005; 56():1-16. PubMed ID: 15660498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematological improvement during iron-chelation therapy in myelodysplastic syndromes: the experience of the "Rete Ematologica Lombarda".
    Molteni A; Riva M; Pellizzari A; Borin L; Freyrie A; Greco R; Ubezio M; Bernardi M; Fariciotti A; Nador G; Nichelatti M; Ravano E; Morra E
    Leuk Res; 2013 Oct; 37(10):1233-40. PubMed ID: 23906627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelodysplastic syndromes: disease overview and therapy options.
    Coutré S
    Manag Care; 2008 Jul; 17(7 Suppl 6):3-8. PubMed ID: 19093333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The strategy for the treatment of myelodysplastic syndromes].
    Hideaki M
    Rinsho Ketsueki; 2002 Mar; 43(3):157-60. PubMed ID: 11979745
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful bone marrow plus cord blood stem cell transplantation in a girl who developed myelodysplastic syndrome from hepatitis-associated aplastic anemia treated with long-term immunosuppressants and growth factors.
    Shibuya A; Ishii S; Obinata K
    Hematology; 2002 Oct; 7(5):301-4. PubMed ID: 12850817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cell transfusion therapy and iron chelation in patients with myelodysplastic syndromes.
    Malcovati L
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S305-11. PubMed ID: 19778858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evidence-based therapy for myelodysplastic syndrome].
    Toyama K
    Nihon Naika Gakkai Zasshi; 2003 Jun; 92(6):992-8. PubMed ID: 12866444
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of myelodysplastic syndromes with hemopoietic growth factors.
    Greenberg PL
    Semin Oncol; 1992 Feb; 19(1):106-14. PubMed ID: 1371018
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment options for myelodysplastic syndromes.
    Stone R
    Cancer Control; 2004; 11(6 Suppl):7-10. PubMed ID: 15625531
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of myelodysplastic syndromes in adults: guidelines from the Belgian Haematological Society.
    Meers S; Breems D; Bries G; Delforge M; Graux C; Ravoet C; Selleslag D; Noens L;
    Acta Clin Belg; 2013; 68(4):253-62. PubMed ID: 24455794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.